20 September 2018 - Half of all generic prescriptions could come from one supplier after the competition watchdog approved a merger between two pharmaceutical companies.
India’s Strides Pharma Science, operating in Australia and New Zealand as Arrow Pharmaceuticals, is seeking to merge with the local arm of Toronto-based company Apotex.
The pair import and distribute generic prescriptions - non-branded medications - including vitamins and drugs sold over the counter.